Abstract:
The Pompidou Group was set up in 1971 to provide a forum for exchanging views and concerting action in Western Europe in response to the growing drugs problem. Until 1979 it had no formal status, but in 1980 the Group became part of the Council of Europe with member States being free to choose whether to join or not. Its initial membership of six countries has expanded to 16 members. Every two to three years, ministers from member countries meet to review the work of the Group and to set a new programme of activities. Government officials (Permanent Correspondents) then meet to further the programme by arranging meetings, working groups, seminars, symposia and related activities of experts in particular fields. The Group has considered a wide variety of topics of general interest, which included: European cooperation in the control of drug traffic; problems connected with drug addicts in prison; the care of hard-core addicts; problems related to the staffing of treatment and rehabilitation services; the development of administrative monitoring systems for the assessment of public health and social problems related to drug misuse; drug trafficking on the high seas; the role of the criminal justice system in responding to the needs of drug misusers; methods of reaching young people particularly at risk; problems concerning women and drugs; control services at major European airports; cannabis misuse in Europe; acquired immunodeficiency syndrome among drug misusers; and consideration of elements for inclusion in a new United Nations convention against illicit traffic in narcotic drugs and psychotropic substances.
Keywords: Acquired Immunodeficiency Syndrome/TRANSMISSION Adolescence Criminal Law Europe Female Health Occupations/EDUCATION Human *International Agencies International Cooperation Prisons Street Drugs/SUPPLY & DISTRIBUTION Substance Abuse/*PREVENTION & CONTROL/THERAPY JOURNAL ARTICLE
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.
